financetom
Business
financetom
/
Business
/
Kennametal Insider Sold Shares Worth $313,140, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kennametal Insider Sold Shares Worth $313,140, According to a Recent SEC Filing
May 13, 2024 12:22 PM

02:57 PM EDT, 05/13/2024 (MT Newswires) -- Michelle R Keating, Vice President, on May 09, 2024, sold 12,000 shares in Kennametal ( KMT ) for $313,140. Following the Form 4 filing with the SEC, Keating has control over a total of 33,008 shares of the company, with 33,008 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/55242/000153003824000001/xslF345X03/primary_doc.xml

Price: 25.89, Change: +0.13, Percent Change: +0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ally Financial Appoints Michael Rhodes as CEO
Ally Financial Appoints Michael Rhodes as CEO
Mar 27, 2024
04:41 PM EDT, 03/27/2024 (MT Newswires) -- Ally Financial ( ALLY ) said late Wednesday it has appointed Michael Rhodes as chief executive officer, effective April 29. Rhodes, who most recently served as CEO of Discover Financial Services ( DFS ), succeeds Jeffrey Brown, who stepped down in January, the company said. ...
The Westaim Corporation Reports Q4 And Full Year 2023 Results
The Westaim Corporation Reports Q4 And Full Year 2023 Results
Mar 27, 2024
04:43 PM EDT, 03/27/2024 (MT Newswires) -- The Westaim Corporation ( WEDXF ) Wednesday announced its audited financial results for the quarter and full year ending Dec. 31, 2023. Westaim ( WEDXF ) recorded a net profit of US$35.1 million (US$0.26 diluted earnings per share) for Q4 2023 compared to a net profit of US$32.8 million (US$0.23 diluted earnings per...
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing
Mar 27, 2024
04:41 PM EDT, 03/27/2024 (MT Newswires) -- Johannes Jacob Pieter Kastelein, Director, Chief Scientific Officer, on March 26, 2024, sold 190,476 shares in Newamsterdam Pharma ( NAMS ) for $4,095,234. SEC Filing: https://www.sec.gov/Archives/edgar/data/1936258/000095017024037241/xslF345X03/ownership.xml ...
L3harris Technologies Insider Sold Shares Worth $9,814,933, According to a Recent SEC Filing
L3harris Technologies Insider Sold Shares Worth $9,814,933, According to a Recent SEC Filing
Mar 27, 2024
04:42 PM EDT, 03/27/2024 (MT Newswires) -- Christopher E Kubasik, Director, Chair and CEO, on March 25, 2024, sold 46,258 shares in L3harris Technologies ( LHX ) for $9,814,933. Following the Form 4 filing with the SEC, Kubasik has control over a total of 159,222 shares of the company, with 116,175 shares held directly and 43,047 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved